Universidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Molecular Mechanisms Driven by MT4-MMP in Cancer Progression

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

2016

  1. Small GSK-3 Inhibitor shows efficacy in a motor neuron disease murine model modulating autophagy

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Analysis of β-N-methylamino-l-alanine (L-BMAA) neurotoxicity in rat cerebellum

    NeuroToxicology, Vol. 48, pp. 192-205

  2. Morphometric and neurochemical alterations found in l-BMAA treated rats

    Environmental Toxicology and Pharmacology, Vol. 39, Núm. 3, pp. 1232-1245

  3. Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y)

    Neuroscience Letters, Vol. 593, pp. 83-89

2013

  1. Effect of β-N-methylamino-l-alanine on oxidative stress of liver and kidney in rat

    Environmental Toxicology and Pharmacology, Vol. 35, Núm. 2, pp. 193-199

  2. In utero hepatocellular transplantation in rats

    Clinical and Developmental Immunology, Vol. 2013

  3. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): The first step towards an experimental model for sporadic ALS

    Environmental Toxicology and Pharmacology, Vol. 36, Núm. 2, pp. 243-255

  4. β-n-methylamino-L-alanine induces changes in both GSK3 and TDP-43 in human neuroblastoma

    Journal of Toxicological Sciences